🇺🇸 FDA
Patent

US 12076347

Methods for production of platelets from pluripotent stem cells and compositions thereof

granted A61KA61K35/19A61P

Quick answer

US patent 12076347 (Methods for production of platelets from pluripotent stem cells and compositions thereof) held by Astellas Institute for Regenerative Medicine expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K35/19, A61P, A61P17/02, A61P33/06